Adverum Biotechnologies (ADVM) Insider Trading & Ownership $4.29 -0.27 (-5.92%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$4.33 +0.04 (+0.93%) As of 10/17/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Adverum Biotechnologies (NASDAQ:ADVM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$863.04KNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$26.02K Get ADVM Insider Trade Alerts Want to know when executives and insiders are buying or selling Adverum Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADVM Insider Buying and Selling by Quarter Adverum Biotechnologies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2025Laurent FischerCEOSell9,126$2.00$18,252.00 5/15/2025Peter SoparkarCOOSell2,960$2.00$5,920.00 5/15/2025Setareh SeyedkazemiInsiderSell924$2.00$1,848.00 4/23/2025Braden Michael LeonardMajor ShareholderBuy50,000$2.98$149,000.00 4/2/2025Braden Michael LeonardMajor ShareholderBuy15,209$4.04$61,444.36 3/31/2025Braden Michael LeonardMajor ShareholderBuy19,566$4.38$85,699.08 3/26/2025Braden Michael LeonardMajor ShareholderBuy20,407$5.04$102,851.28 3/20/2025Braden Michael LeonardMajor ShareholderBuy30,600$5.61$171,666.00 3/18/2025Braden Michael LeonardMajor ShareholderBuy62,341$4.69$292,379.29 (Data available from 1/1/2013 forward) ADVM Insider Trading Activity - Frequently Asked Questions Who is on Adverum Biotechnologies' Insider Roster? The list of insiders at Adverum Biotechnologies includes Braden Michael Leonard, Brigit Riley, James Paul Scopa, Laurent Fischer, Peter Soparkar, and Setareh Seyedkazemi. Learn more on insiders at ADVM. What percentage of Adverum Biotechnologies stock is owned by insiders? 6.00% of Adverum Biotechnologies stock is owned by insiders. Learn more on ADVM's insider holdings. Which Adverum Biotechnologies insiders have been buying company stock? The following insiders have purchased ADVM shares in the last 24 months: Braden Michael Leonard ($2,526,991.51), and James Paul Scopa ($135,000.00). How much insider buying is happening at Adverum Biotechnologies? Insiders have purchased a total of 429,469 ADVM shares in the last 24 months for a total of $2,661,991.51 bought. Which Adverum Biotechnologies insiders have been selling company stock? The following insiders have sold ADVM shares in the last 24 months: Laurent Fischer ($18,252.00), Peter Soparkar ($5,920.00), and Setareh Seyedkazemi ($1,848.00). How much insider selling is happening at Adverum Biotechnologies? Insiders have sold a total of 13,010 Adverum Biotechnologies shares in the last 24 months for a total of $26,020.00 sold. Adverum Biotechnologies Key ExecutivesDr. Laurent Fischer (Age 60)President, CEO & Director Compensation: $1.02M1 recent tradesMs. Linda M. Rubinstein M.A. (Age 57)CFO, Principal Financial Officer & Principal Accounting Officer Compensation: $940.99kMr. Kishor Peter Soparkar J.D. (Age 53)Chief Operating Officer Compensation: $674.98kDr. Setareh Seyedkazemi Pharm.D. (Age 50)Chief Development Officer Compensation: $656.84kDr. R. Andrew Ramelmeier Ph.D. (Age 62)Chief Technology Officer Dr. Romuald Corbau Ph.D. (Age 55)Chief Scientific Officer Mr. John W. Rakow J.D. (Age 67)Senior VP & General Counsel Compensation: $954.24kMs. Dena HouseChief People OfficerMs. Carla FiankanSenior Vice President of Regulatory AffairsMr. Michael SteelSenior Vice President of Quality More Insider Trading Tools from MarketBeat Related Companies KRRO Insider Trades EOLS Insider Trades BNTC Insider Trades YMAB Insider Trades DSGN Insider Trades IVVD Insider Trades AMRN Insider Trades UPXI Insider Trades RCKT Insider Trades AURA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry This page (NASDAQ:ADVM) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThis dark force is about to change everythingSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
